Clinical trialNCT07422480RecruitingPhase 3Interventional

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

SponsorTakedaEnrollment300AnemiaMyelodysplastic Syndrome

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Study Director
Takeda
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

154 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Hospital Privado de Cordoba
Córdoba, Córdoba Province, Argentina
Ana Basquiera
Not, yet, recruiting
Instituto Medico de la Fundacion Estudios Clinicos
Rosario, Santa Fe Province, Argentina
Gustavo Jorge Braidot
Not, yet, recruiting
Swiss Medical Center - Barrio Parque
Buenos Aires, Argentina
Claudio Marcelo Iastrebner
Not, yet, recruiting
Sanatorio Allende S.A. - Nueva Cordoba
Córdoba, Argentina
Gustavo D Jarchum
Not, yet, recruiting

Australia

Mid North Coast Local Health District - Mid North Coast Cancer Institute (mncci) - Coffs Harbour
Coffs Harbour, New South Wales, Australia
Kyle Crassini
Not, yet, recruiting
South Eastern Sydney Local Health District
Sydney, New South Wales, Australia
Sundreswran Ramanathan
Not, yet, recruiting
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Anoop Enjeti
Not, yet, recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Devendra Hiwase
Not, yet, recruiting
Flinders Medical Centre
Bedford Park, South Australia, Australia
Ashanka Beliasgwatte
Not, yet, recruiting
Monash University-Monash Medical Centre (mmc) - Clayton
Clayton, Victoria, Australia
Jake Shortt
Not, yet, recruiting
St. Vincent'S Hospital Melbourne
Fitzroy, Victoria, Australia
Shuhying Tan
Not, yet, recruiting
Eastern Haematology & Oncology Group Or Austin Hospital
Heidelberg, Victoria, Australia
Chun Yew Fong
Not, yet, recruiting
Alfred Hospital
Richmond, Victoria, Australia
Shaun Fleming
Not, yet, recruiting
Fiona Stanley Hospital
Perth, Western Australia, Australia
Jasmine Singh
Not, yet, recruiting

Belgium

Chu-Ucl Namur Site Godinne
Yvoir, Namur, Belgium
FRANCOIS DACHY
Not, yet, recruiting
Uz Leuven
Leuven, Vlaams-Brabant, Belgium
Marielle Beckers
Not, yet, recruiting
Az Delta (h.-Hartziekenhuis Roeselare-Menen Vzw (hhrm)) - Campus Rumbeke
Roeselare, West Flanders, Belgium
Dries Deeren
Not, yet, recruiting

Brazil

D'Or Institute for Research and Education
Salvador, Estado de Bahia, Brazil
Laine Santos Fiscina Alvarenga
Not, yet, recruiting
Hospital Mae de Deus, Clinical Research Unit - Cancer Institute
Porto Alegre, Rio Grande do Sul, Brazil
Marcelo Capra
Not, yet, recruiting
Porto Alegre Clinical Hospital (hcpa)
Porto Alegre, Rio Grande do Sul, Brazil
Laura Maria Fogliatto
Not, yet, recruiting
Centro de Hematologia E Oncologia (cho)
Joinville, Santa Catarina, Brazil
Ana Claudia Dall'Oglio
Not, yet, recruiting
Hospital Amaral Carvalho (hac)
Jaú, São Paulo, Brazil
Ederson Mattos
Not, yet, recruiting
Irmandade Da Santa Casa Da Misericordia de Santos (iscms)
Santos, São Paulo, Brazil
Elaine Mancilha
Not, yet, recruiting
Hospital 9 de Julho (rede Americas/dasa)
São Paulo, Brazil
Vinicius Molla
Not, yet, recruiting
Portuguese Charity of Sao Paulo, Clinical Hematology / Oncology Center
São Paulo, Brazil
Phillip Scheinberg
Not, yet, recruiting

Bulgaria

Dr. Pencho Georgiev - Outpatient Center for Individual Practice for Specialized Medical Care in Internal Medicine and Clinical Hematology (eood)
Plovdiv, Bulgaria
Pencho Georgiev
Recruiting
Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Clinic of Hematology
Sofia, Bulgaria
Tanya Yankova
Not, yet, recruiting

France

Centre Hospitalier Universitaire Grenoble Alpes
La Tronche, Isere, France
Mathieu Meunier
Not, yet, recruiting
Poitiers University Hospital Center - Miletrie Site
Poitiers, Vienne, France
Jose Miguel Torregrosa-Diaz
Not, yet, recruiting
Gustave Roussy
Villejuif, X, France
Christophe Willekens
Not, yet, recruiting
Centre Hospitalier Universitaire (chu) de Nice - Hopital L'Archet I - Hematologie Clinique
Nice, France
Thomas Cluzeau
Not, yet, recruiting
Saint-Louis Hospital
Paris, France
Lionel Ades
Not, yet, recruiting

Germany

Universitatsklinikum Bayreuth, Med. Klinik Iv
Bayreuth, Bavaria, Germany
Alexander Kiani
Not, yet, recruiting
Gemeinschaftspraxis Fuer Haematologie Und Onkologie - Praxis Steinfurter Strasse
Münster, North Rhine-Westphalia, Germany
Ruediger Liersch
Not, yet, recruiting
University Hospital Halle (saale), Department of Internal Medicine Iv - Hematology and Oncology
Halle, Saxony-Anhalt, Germany
Haifa Al-Ali
Not, yet, recruiting
Charite Campus Benjamin Franklin
Berlin, Germany
Kathrin Rieger
Not, yet, recruiting
Praxis Am Volkspark
Berlin, Germany
Jan-Piet Habbel
Recruiting

Greece

Laiko General Hospital
Athens, Central Athens, Greece
Theodoros Vassilakopoulos
Not, yet, recruiting
National and Kapodistrian University of Athens (nkua)-Laiko General Hospital
Athens, Central Athens, Greece
Panagiotis Diamantopoulos
Not, yet, recruiting
Democritus University of Thrace (duth) - University General Hospital of Alexandroupolis
Alexandroupoli, Evros, Greece
Ioannis Kotsianidis
Not, yet, recruiting

114 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Elritercept →Epoetin alfa →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 May 2026
Primary completion: 30 Apr 2029
Completion: 1 Oct 2033
Last update posted: 15 Jun 2026
Registered enrollment: 300
Registry id: NCT07422480

Cross-registrations

EU-CTR / CTIS (EudraCT)2025-523544-12-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.